Development of Three-dimensional Scaffold Models Suitable for the Study of Prostate Cancer Progression
No Thumbnail Available
Date
2025
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Saudi Digital Library
Abstract
Prostate cancer (PC) is one of the leading causes of cancer-related death in men
worldwide. In advanced PC, cancer cells undergo an epithelial-to-mesenchymal transition
(EMT) process, characterised by increasing mesenchymal factors, leading to metastasis.
At the metastatic sites, cells undergo a mesenchymal-to-epithelial (MET) process,
characterised by increasing epithelial and angiogenic factors for more stable colonisation.
In recent years, the extracellular matrix (ECM) of the PC tumour microenvironment (TME)
has been recognised as a critical player in cancer development and the EMT process.
The ECM of prostate tissue consists of collagen and various constituents, including
chondroitin sulfate (CS) and hyaluronic acid (HyA), which significantly increase during PC
progression and warrant further investigation. Due to their inherent limitations, 2D cultures
cannot entirely mimic the in vivo ECM of PC TME, displaying significant differences in cell
shape, proliferation, and differentiation. Therefore, this project aims to develop
physiologically relevant 3D collagen-based scaffolds containing different concentrations
of CS and HyA to mimic the ECM of PC and be suitable for studying the EMT process,
evaluating anti-cancer therapeutics, including chemotherapy and gene therapy, and
studying the PC bone metastasis in bone-mimicking scaffolds.
In Chapter 2 of this thesis, four collagen-based scaffolds were successfully developed
and characterised. The scaffolds were named according to CS and HyA concentration
(Col/CS low, Col/CS high, Col/HyA low and Col/HyA high). The scaffolds revealed
excellent biocompatibility and facilitated the attachment and survival of two PC cell lines,
LNCaP and PC-3. Additionally, the scaffolds maintained the typical phenotype of PC cells,
confirming their suitability for PC research.
Chapter 3 focused on examining the influence of ECM components, including CS and
HyA, on the EMT process of PC using the scaffolds developed in Chapter 2. The findings
indicated that CS promotes EMT and aggressiveness in PC cells by stimulating the
expression of mesenchymal markers, metastatic markers, and pro-inflammatory,
angiogenic, and proliferation-related cytokines, particularly in PC-3 cells. On the other
hand, HyA was found to suppress EMT in LNCaP cells by enhancing epithelial marker
expression and reducing angiogenic cytokines. This highlighted the crucial functions of
ECM components in regulating EMT and PC advancement.
In Chapter 4, the scaffolds created in Chapter 2 were used to assess the chemotherapy
response generated by PC in a 3D environment compared to the 2D culture. Moreover,
the potential therapeutic effect of miRNA-23a (miR-23a) was evaluated using these
scaffolds as novel gene therapy. The results underscored the role of CS in promoting
chemoresistance in PC-3 cells, making it the perfect target to assess the effect of miR-
23a overexpression in PC progression. The study showed that miR-23a can inhibit cell
migration, invasiveness, metastatic behaviour, and aggressive phenotype. This indicates
that miR23-a is a promising gene therapy in PC and highlights the efficiency of collagen-
based scaffolds.
Finally, a bone-mimicking collagen-nanohydroxyapatite scaffold was used as a platform
to mimic PC bone metastasis in Chapter 5 and study the cellular interactions within the
TME. The study was designed by co-culturing different osteoblast maturities with PC cells
(LNCaP and PC-3) to examine their relationships more deeply and simulate the TME. The
co-culture systems revealed that the scaffolds mimic the TME of PC bone metastasis,
highlighting the role that osteoblasts play in shaping the morphology, proliferation, and
migration of PC cells. The results also showed that co-culture of PC cells with osteoblasts
supported bone remodelling and activated MET processes for more stable colonisation.
These investigations confirmed the ability of the scaffolds to simulate the interactions
between tumours and stroma found in PC bone metastases.
In conclusion, this thesis successfully introduced collagen-based scaffolds incorporating
native ECM components (CS and HyA) as physiologically relevant 3D models for PC
research. These models provided valuable insight into mechanisms driving PC
progression, EMT, and therapeutic resistance while offering a platform for evaluating
novel treatments, including gene therapy. The co-culture systems further expand their
application to studying tumour-stroma and cell-cell interactions, particularly in bone
metastasis, making it a valuable tool for in vitro studies for PC research.
Description
General Impact of This Thesis
This thesis developed a series of 3D collagen-based scaffold biomimetic models that mimic key stages of PC progression, from primary tumour growth to bone metastasis. By incorporating native ECM components such as CS, HyA, and nHA, and by using them as a co-culture system with relevant stromal cells, these scaffolds capture both the biochemical and biomechanical features of the TME. The models provide an adaptable platform to study tumour-stroma interactions, EMT and MET processes, and therapy responses in a controlled and physiologically relevant setting.
The ability to adapt these collagen-based scaffolds for different applications, including modelling bone metastasis through co-culture with osteoblasts of different maturities, highlights their potential use for drug screening, reducing the need for animal models, and improving clinical translation. Together, these models bridge the gap between simple in vitro culturing systems and complex in vivo systems, offering a valuable tool for advancing PC research and developing new therapeutic strategies.
Keywords
Tissue engineering, Prostate cancer, Collagen-based scaffolds, Gene therapy, Co-culture
Citation
Vancouver style: